India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin.
Hosted on MSN8h
GSK Pharma Q3 results 2025: PAT ZOOMS 402% YoY, Revenue at Rs 949 cr - Check quarterly earningsGlaxoSmithKline Pharma Ltd announced its Q3 results today posting a solid jump in its net profit. Consolidated PAT for the ...
GlaxoSmithKline Pharmaceuticals Ltd reported an 18% revenue increase to ₹946 crore for Q3 ended December 31, 2024, with a ...
Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,03,189.17 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...
Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends in the pharmaceutical sector.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback